#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Scedosporium infection Congenital myopathy Ductal adenocarcinoma of pancreas Drug eruption Choroid melanoma Ventricular tachycardia Malignant neoplasm of choroid Chordoma Emphysema Astrocytoma malignant Retinopathy proliferative Lennox-Gastaut syndrome Leiomyosarcoma Sarcoma Glioma More trials…

    Learn about Rare Diseases

    Acquired haemophilia – Basic Information Cystic fibrosis lung – Trials in Disease Angiosarcoma non-metastatic Idiopathic inflammatory myopathy – Diagnostics Indolent systemic mastocytosis – Treatment Encephalitis autoimmune Systemic mastocytosis – Treatment Soft tissue sarcoma – Diagnostics Myelodysplastic syndrome – Trials in Disease Synovial sarcoma recurrent – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ethinylestradiol LY3841136 SODIUM Ngi226 ZALFERMIN Omp72 Peboctocogene Camaparvovec Ucart20X22 A/H1N1 INFLUENZA VACCINE Cefoxitin Prilocaine Festuca Elatior Pollen Extract Follitropin Beta Teverelix FOSFOMYCIN CALCIUM Linvoseltamab H2-Receptor Antagonists Isoflurane Reboxetine Acetylsalicylic Acid Finasteride More therapies…

    Learn about Your Condition

    Follicular lymphoma Colorectal adenocarcinoma Growth hormone deficiency Psychotic disorder Neuroblastoma Endocarditis bacterial Neurotrophic keratopathy Thyroidectomy Usher's syndrome Obstructive airways disorder Intestinal infarction Pre-eclampsia Cholecystitis acute Pelizaeus-Merzbacher disease Thyroid cancer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on Nicotine Patch for Preventing Delayed Gastric Emptying in Patients After Pancreatoduodenectomy

    Recruiting

    2 1 1
    Investigated Diseases:
    • Pancreaticoduodenectomy
    Investigated Drugs:
    • Nicotine
    Germany

  • Study on the Effects of Imipramine in Patients with Colon, Rectal, or Breast Cancer Over-Expressing Fascin1

    Recruiting

    2 1 1
    Investigated Diseases:
    • Colon cancer stage II
    • Colon cancer stage III
    • Rectal cancer
    Investigated Drugs:
    • Imipramine Hydrochloride
    Spain

  • Study on the Effectiveness of Botulinum Toxin A and Sodium Chloride for Patients with Trigeminal Neuralgia

    Recruiting

    3 1 1
    Investigated Diseases:
    • Trigeminal neuralgia
    Investigated Drugs:
    • Botulinum Toxin Type A
    • Sodium Chloride
    Denmark

  • Study on the Effects of Carboplatin and Cisplatin in Patients with Early-Stage, Intermediate-Risk Cervical Cancer

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Carboplatin
    • Cisplatin
    Austria Belgium Czechia Italy Poland Spain

  • Study for Patients with Various Tumor Types Continuing Osimertinib Treatment After Previous Oncology Study Completion

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Osimertinib
    France Poland

  • Study on the Use of Romosozumab and Zoledronic Acid for Treating Osteoporosis in Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Osteoporosis
    Investigated Drugs:
    • Zoledronic Acid
    • Romosozumab
    Denmark
Previous Page
1 … 600 601 602 603 604 … 1,654
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!